ZAGRAPA 0.25 mg/ml, eye drop solution in a single-dose container 30 single-dose containers of 0.4 ml
Active ingredients: Ketotifen fumarate, KETOTIFÈNE
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solution30 single-dose containers of 0.4 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZAGRAPA 0,25 mg/ml, collyre en solution en récipient unidose
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 30 récipient(s) unidose(s) polyéthylène basse densité (PEBD) de 0,4 ml
- Marketing authorisation holder
- THEA
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Dec 2023
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68634477CIP73560774CIP133400935607744Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FUMARATE DE KETOTIFÈNEcollyre | 0,138 mg · 0,4 ml | SA |
| KETOTIFÈNEcollyre | 0,1 mg · 0,4 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.